|Project #||Project Title||Research Focus Area||Research Program||Administering IC(s)||Institution(s)||Investigator(s)||Location(s)||Year Awarded|
|Virtual Reality as a Opioid Sparing Intervention for Acute Postoperative Pain Management||Cross-Cutting Research||Small Business Programs||NIDA||APPLIEDVR, INC||AYAD, SABRY; KESHOCK, MAUREEN; POWERS, JOE; STEARNS, KIM; SUK, MICHAEL||Los Angeles, CA||2019|
FOA Title: HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)
FOA Number: RFA-DA-19-019
Millions of Americans undergo surgery each year, with fewer than half of patients reporting adequate postoperative pain relief and approximately 75 percent reporting moderate to severe postoperative pain. Gaps in postoperative pain management that lead to the unnecessary introduction and over-prescription of opioids continue to exacerbate the opioid crisis, but virtual reality (VR) has been demonstrated to be an effective strategy for pain management. This project will enhance and improve the functionality of a VR-based technology, AppliedVR, to provide acute perioperative pain management through a new software-based VR medical device, RelieVRx™. As a non-opioid alternative intended to reduce postoperative pain, RelieVRx can potentially reduce the need for and utilization of opioids in the postoperative setting.